Picard Medical, Inc. (PMI)

Picard Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec 31, 2025	Dec 31, 2024
Revenue	4.94	4.39
Revenue Growth (YoY)	12.50%	-
Cost of Revenue	5.14	4.5
Gross Profit	-0.2	-0.11
Selling, General & Admin	10	10.22
Research & Development	3.05	3.38
Total Operating Expenses	13.05	13.6
Operating Income	-13.26	-13.71
Interest Expense	-5.39	-3.07
Other Non-Operating Income (Expense)	-8.32	-4.29
Total Non-Operating Income (Expense)	-13.71	-7.36
Pretax Income	-26.97	-21.07
Provision for Income Taxes	0.04	-0.02
Net Income	-27	-23.74
Net Income Attributable to Preferred Dividends	-	2.68
Net Income to Common	-27	-23.74
Shares Outstanding (Basic)	36	8
Shares Outstanding (Diluted)	36	8
Shares Change (YoY)	356.13%	-
EPS (Basic)	-0.75	-2.99
EPS (Diluted)	-0.75	-2.99
Shares Outstanding	73.7	7.94
Free Cash Flow	-15.67	-11.87
Free Cash Flow Per Share	-0.43	-1.49
Gross Margin	-4.13%	-2.55%
Operating Margin	-268.36%	-312.27%
Profit Margin	-546.60%	-479.50%
FCF Margin	-317.27%	-270.42%
EBITDA	-13.09	-13.49
EBITDA Margin	-265.06%	-307.13%
EBIT	-13.26	-13.71
EBIT Margin	-268.36%	-312.27%
Effective Tax Rate	-0.13%	0.07%

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q